Peg-filgrastim potentiates rituximab in patients with indolent lymphomas: results of a phase II study
Torka, Pallawi, MD, Patel, Priyank, MD, Tan, Wei, MS, Wilding, Gregory, PhD, Mavis, Cory, MS, Deeb, George, Lee, Kelvin, Bhat, Seema, Czuczman, Myron, Hernandez-Ilizaliturri, Francisco J
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article